The WISeR (Wasteful and Inappropriate Service Reduction) model will use artificial intelligence (AI) technology to review physicians’ recommended treatments for a number of medical conditions for ...
In today’s Pharma Pulse, global pharmaceutical production hits a surge as manufacturers brace for US tariff shifts, while a new study reveals how smart speakers are slashing A1C levels for older ...
In the second part of his Pharma Commerce video interview, Hari Kiran Chereddi, CEO of HRV Pharma, describes how AI-driven ...
How direct-to-patient programming can transform the prescription journey for patients and manufacturers alike. The status quo ...
In today’s Pharma Pulse, over 200 health groups denounce childhood vaccine schedule cuts, GSK acquires RAPT Therapeutics, and ...
In the final part of his Pharma Commerce video interview, Alan Balch, PhD, CEO of the Patient Advocate Foundation and the ...
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innov ...
In the final part of his Pharma Commerce video interview, Franco Stevanato, CEO of Stevanato Group, explains that with plant ...
The collaboration between ten23 health and BD aims to commercialize the BD Libertas wearable injector for large-volume ...
In today’s Pharma Pulse, the United States finalizes its departure from global health oversight, while domestic providers face a record-breaking surge in respiratory hospitalizations.
In today’s Pharma Pulse, Novartis calls for a shift from "cost-containment" to structural reform, hospital mergers hit their ...
Balch’s perspective underscores the broader affordability crisis facing working families and highlights how rising premiums ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results